Observational Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jul 27, 2025; 17(7): 106026
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.106026
Table 2 Comparison of clinical information
Variables
Total (n = 264)
Normal group (n = 96)
FCR group (n = 168)
Statistic
P value
Duration of diseaseχ² = 5.610.018
≥ 1 year115 (43.56)51 (53.12)64 (38.10)
< 1 year149 (56.44)45 (46.88)104 (61.90)
Tumor diameterχ² = 5.460.020
< 5 cm154 (58.33)65 (67.71)89 (52.98)
≥ 5 cm110 (41.67)31 (32.29)79 (47.02)
Clinical stagingχ² = 2.160.141
Phase I and II204 (77.27)79 (82.29)125 (74.40)
Phase III and IV60 (22.73)17 (17.71)43 (25.60)
Pathological typeχ² = 0.090.770
Other52 (19.70)18 (18.75)34 (20.24)
Adenocarcinoma212 (80.30)78 (81.25)134 (79.76)
Multiple fociχ² = 2.700.101
No227 (85.98)87 (90.62)140 (83.33)
Yes37 (14.02)9 (9.38)28 (16.67)
Lesion siteχ² = 0.050.974
Upper part89 (33.71)33 (34.38)56 (33.33)
Middle part82 (31.06)30 (31.25)52 (30.95)
Lower part93 (35.23)33 (34.38)60 (35.71)
H. pyloriχ² = 0.440.506
No68 (25.76)27 (28.12)41 (24.40)
Yes196 (74.24)69 (71.88)127 (75.60)
Postoperative complicationsχ² = 4.580.032
No216 (81.82)85 (88.54)131 (77.98)
Yes48 (18.18)11 (11.46)37 (22.02)